{"url_path":"/sec/tpst/8-k/2026-06-02/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-02","source_url":"https://www.sec.gov/Archives/edgar/data/1544227/0001193125-26-251994-index.html","accession_number":"0001193125-26-251994","cik":"0001544227","ticker":"TPST","issuer_name":"Tempest Therapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1544227/0001193125-26-251994-index.html","primary_entity_key":"0001544227","primary_entity_name":"Tempest Therapeutics, Inc."},"word_count":89,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits\n\n(d) Exhibits\n\n \n\n10.1\n  \n[Form of Warrant Exercise and Inducement Offer Letter](d105562dex101.htm)\n\n10.2\n  \n[Form of New Warrant](d105562dex102.htm)\n\n10.3\n  \n[Form of Placement Agent Warrant](d105562dex103.htm)\n\n104\n  \nCover Page Interactive Data File (formatted in Inline XBRL)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nTEMPEST THERAPEUTICS, INC.\n\nDate: June 1, 2026\n \n\n \nBy:\n \n\n/s/ Matthew Angel\n\n \n\n \nName:\n \nMatthew Angel\n\n \n\n \nTitle:\n \nPresident and Chief Executive Officer"}